Cargando…
Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial
PURPOSE: The most effective treatments in elderly patients with esophageal cancer remain a subject of debate. This multicenter phase 2 study was designed to evaluate the efficacy and toxicity of chemoradiation therapy (CRT) with docetaxel (DTX) in elderly patients with stage II/III (non-T4) esophage...
Autores principales: | Ohba, Akihiro, Kato, Ken, Ito, Yoshinori, Katada, Chikatoshi, Ishiyama, Hiromichi, Yamamoto, Sachiko, Ura, Takashi, Kodaira, Takeshi, Kudo, Shigehiro, Tamaki, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514160/ https://www.ncbi.nlm.nih.gov/pubmed/28740892 http://dx.doi.org/10.1016/j.adro.2016.07.002 |
Ejemplares similares
-
Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study
por: Kato, Ken, et al.
Publicado: (2018) -
Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020) -
Influence of Caregiver Presence During Physician Office Visits on Patients Undergoing Chemoradiation Therapy for Esophageal Cancer
por: Ho, Joseph K., et al.
Publicado: (2021) -
Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review
por: Rahimy, Elham, et al.
Publicado: (2020) -
Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer
por: Montovano, Margaret, et al.
Publicado: (2021)